CBIO · Crescent Biopharma, Inc.
$17.15
+0.92 (+5.67%)
At close · Aug 21
Market Cap
$637.02M
Shares
37.14M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding CBIO
7 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 698,846 | $12,837,801 | 0.00% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 81,936 | $1,505,164 | 0.00% | Long | 2026-03-31 | |
| Avantis U.S. Small Cap Equity ETF | — | 15,612 | $322,388 | 0.01% | Long | 2026-05-31 | |
| VANGUARD BALANCED INDEX FUND | — | 12,607 | $231,591 | 0.00% | Long | 2026-03-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 8,006 | $147,070 | 0.00% | Long | 2026-03-31 | |
| Victory Extended Market Index Fund | — | 2,240 | $50,109 | 0.01% | Long | 2026-04-30 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 114 | $2,550 | 0.00% | Long | 2026-04-30 |
Showing 1–7 of 7 positions
Key facts
CIK
1253689
CUSIP
G2545C104
13F (30d)
75 filings
75 filers
Visit website
Investor relations